share_log

东亚药业(605177.SH):枸橼酸莫沙必利原料药获得韩国原料药品注册证书

Zhejiang East-Asia Pharmaceutical (605177.SH): The active pharmaceutical ingredient Mosapride Citrate has obtained the original pharmaceutical registration certificate in South Korea.

Gelonghui Finance ·  Dec 4 15:37

Gelonghui December 4th | Zhejiang East-Asia Pharmaceutical (605177.SH) announced that it has received the active pharmaceutical ingredient registration certificate from the South Korea Food and Drug Administration (MFDS) for the product named Mosapride Citrate. Mosapride Citrate is used for functional dyspepsia accompanied by gastric heartburn, belching, nausea, vomiting, early satiety, epigastric bloating, and other digestive symptoms; it can also be used for gastroesophageal reflux disease, diabetic gastroparesis, and gastric functional disorders in some patients with partial gastrectomy.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment